1. Introduction {#s0005}
===============

Tremor is a common and often debilitating symptom associated with many neurological disorders such as Parkinson disease, dystonia, and essential tremor (ET). ET has been regarded as the most common pathologic tremor disorder ([@bb0115]; [@bb0065]). Although the underlying oscillators of many tremor syndromes remain unknown, the collective evidence regarding ET suggests that the cerebello-thalamo-cortical pathway is central to tremor network dysfunction ([@bb0050]). Many invasive and noninvasive surgical treatment options target modulation of this network ([@bb0050]; [@bb0110]; [@bb0025]; [@bb0090]; [@bb0220]).

One of the most widely targeted brain regions for tremor treatment is the ventral intermediate nucleus (VIM) of the thalamus ([@bb0080]; [@bb0130]). Historically, the use of surgical thalamotomy evolved to thalamic deep brain stimulation (DBS) mainly because of limitations in the treatment of bilateral brain lesions but also because of treatment possibilities introduced by neuromodulation. VIM DBS has been shown to reduce tremor by 50% to 90% at long-term follow-up ([@bb0025]; [@bb0090]; [@bb0220]). However, some patients are not ideal surgical candidates for open DBS procedures, and other approaches have been introduced, including stereotactic radiosurgery (SRS) ([@bb0035]) and magnetic resonance--guided focused ultrasonography (MRgFUS) ([@bb0070]). These latter procedures are much more dependent on accurate imaging because intraoperative electrophysiologic recordings cannot be used to guide treatment.

Preoperative thalamic targeting methods have historically relied on indirect targeting mainly because individual thalamic nuclei are not well resolved with traditional neuroimaging methods. Standard target points can be identified in reference to universally applied coordinates to the anterior-posterior commissure line by using atlas-based methods or stereotaxy-based approaches ([@bb0005]; [@bb0185]). Importantly, these preoperative techniques do not fully account for variations in functional anatomy between patients. By using a preoperative thalamic segmentation scheme based on probabilistic diffusion tensor imaging, Middlebrooks et al. ([@bb0135]) recently showed substantial inter- and intrasubject variability in structural connectivity compared with a fixed coordinate-based stereotactic target. Others have also shown some early success in applying these techniques to define single-subject connectivity profiles in small numbers of patients who underwent thalamic DBS, SRS, and MRgFUS ([@bb0105]; [@bb0160]; [@bb0195]).

The described interindividual variations in thalamic functional anatomy may, in part, contribute to the reported variability in patient outcomes: improvement in tremor reportedly ranges from 18% to 88% ([@bb0205]). In theory, improvements in preoperative targeting techniques may help increase the success rate of using thalamic DBS to treat tremor while reducing the incidence of adverse effects and also maximizing battery life. Therefore, the purpose of this study was to evaluate the potential of using structural connectivity--based segmentation (SCBS) of the thalamus as a preoperative targeting technique. We aimed to correlate location with improvement in tremor following VIM DBS. On the basis of the results of previous studies ([@bb0135]; [@bb0160]) and the outcomes from rescue leads implanted in the ventralis oralis (VO) ([@bb0150]; [@bb0215]), we hypothesized that increasing the volume of tissue activated (VTA) within the segment most connected to the supplementary motor area (SMA) and premotor cortex (PMC) would correlate with improvement in the clinical tremor score.

2. Materials and methods {#s0010}
========================

2.1. Study patients {#s0015}
-------------------

The study used a retrospective design and was approved by the University of Florida Institutional Review Board. An institutional database from the Center for Movement Disorders and Neurorestoration in Gainesville, Florida, of patients who received DBS was queried. Inclusion criteria were as follows: 1) the patient had a diagnosis of ET; 2) the patient received thalamic DBS for tremor; 3) the patient had no prior DBS lead placement; 4) a single lead was implanted during the first surgical procedure; 5) the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) score ([@bb0180]) was recorded immediately before the operation and at the 6-month follow-up; 6) the DBS programming settings were recorded; and 7) an appropriate imaging protocol was used that consisted of preoperative diffusion tensor imaging and postoperative high-resolution computed tomography for lead localization. Patients with dual leads that were placed at the initial surgery were excluded because the isolated effects of each lead could not be assessed. Patients who later underwent a second lead placement did not undergo evaluations of the second lead placement because the inclusion of such patients would have violated the statistical assumption of independent measurements.

A total of 40 such patients with ET who underwent DBS were identified. Demographic and disease information regarding age at DBS, sex, disease duration, and handedness were collected. DBS programming settings that corresponded to the greatest improvement in tremor without unintended adverse effects were also recorded. The TRS score was measured by a practitioner (who was blinded to the DBS parameters evaluated in this study due to the retrospective design) skilled in TRS measurement at a high-volume DBS and movement disorders clinic. TRS was measured at the pre-operative visit and at the 6-month follow-up; a greater TRS score representing worse symptoms. Two different outcomes were then calculated with regard to change in TRS score between the preoperative and 6-month follow-up time points. First, we assessed the raw change in the TRS score (preoperative score minus 6-month follow-up score). Second, the percentage change in the TRS score (\[preoperative score minus 6-month follow-up score\] divided by preoperative score) was measured. For each of these two separate change in TRS score outcomes, a greater change in the TRS score represented a greater improvement in symptoms from the preoperative to the 6-month follow-up visit.

2.2. Image acquisition {#s0020}
----------------------

Imaging data were obtained from each patient\'s clinical preoperative magnetic resonance imaging (MRI) evaluation that was performed to plan DBS. For the purposes of this study, the imaging protocol included a postcontrast T1-weighted magnetization-prepared rapid gradient-echo (MP-RAGE) sequence and multidirectional diffusion-weighted imaging sequence. Each scan was obtained using a 3-T Siemens Verio system (Siemens AG, Healthcare Sector) with a 12-channel head coil.

The multidirectional diffusion-weighted imaging scan was acquired with the following parameters: isotropic resolution = 1.6 × 1.6 × 1.6 mm with no gap; slices = 70; diffusion directions = 64; b value = 1000 s/mm^2^; repetition time = 10,800 ms; echo time = 100 ms; phase partial Fourier = 5/8; generalized autocalibrating partially parallel acquisitions = 2; bandwidth = 1098 Hz/Px; and echo-planar imaging factor = 130. Six total volumes were also obtained with a b value = 0 s/mm^2^.The total imaging time was 12:14 min.

MP-RAGE imaging was acquired in the axial plane after the administration of gadolinium-based intravenous contrast (0.1 mm/kg). The imaging parameters were as follows: in-plane resolution = 0.6 × 0.6 mm; slice thickness = 1.0 mm; repetition time = 1720 ms; echo time = 3.29 ms; inversion time = 865 ms; flip angle = 9°; bandwidth = 170 Hz/Px; phase partial Fourier = 7/8; and generalized autocalibrating partially parallel acquisitions = 2. Image time was 5:16 min.

Postoperative computed tomography images were obtained using a Toshiba Aquilion scanner (Toshiba Medical Systems). Images were obtained with an in-plane resolution of 0.5 × 0.5 mm and 1-mm-thick slices. CT was obtained approximately one month after DBS implantation to minimize the possibility of brain shift or lead migration.

2.3. Surgical procedures for DBS {#s0025}
--------------------------------

A DBS electrode (Model 3387; Medtronic Inc) was used to perform VIM thalamic DBS in each patient on the side contralateral to their most symptomatic upper extremity. We performed a high-resolution, volumetric brain MRI scan before the first procedure, and a Cosman-Roberts-Wells head ring was applied before performing a high-resolution, stereotactic head computed tomography scan on the day of surgery. The MRI and computed tomography scans were fused together using in-house software, and the target was chosen using postcontrast MP-RAGE and fast gray matter acquisition T1 inversion recovery MRI sequences that were paired with a deformable brain atlas to clarify the thalamic anatomy ([@bb0185]). Microelectrode recordings were used to establish the locations of the anterior border of the ventralis caudalis and the sensorimotor hand area of the VIM.

Patients were observed overnight in the hospital before discharge home on postoperative day 1. An implantable pulse generator was implanted in a second, staged outpatient procedure while the patient was under general anesthesia at 1 month after discharge. After 6 months of stimulation, the follow-up TRS score was calculated for each patient. Tremor-suppressing medications were maintained at the preoperative dose for the study duration.

2.4. Imaging preprocessing {#s0030}
--------------------------

Diffusion data underwent standard preprocessing that consisted of realignment and eddy current correction using the Functional MRI of the Brain (FMRIB) Software Library (FSL) version 5.0.10. Using the "eddy" command, we utilized outlier detection with default parameters to assess for any slice in which the average intensity is at least four SDs less than expected as estimated by the Gaussian process prediction. Since head motion is a concern in patients with a tremor disorder, a stringent cutoff for head motion was used and any subjects with \>0.5% of all slices identified as an outlier were excluded from further analysis. This resulted in the exclusion of two subjects leaving a total of 40 subjects in the analysis. All preoperative MRI and postoperative CT images were co-registered using 2-stage linear registration that consisted of rigid and subsequent affine registration by using Advanced Normalization Tools ([@bb0015]). All volumes were then normalized to the MNI_ICBM_2009b_NLIN_ASYM atlas space using the symmetric image normalization and registration approach that is available by using Advanced Normalization Tools using the pre-operative MP-RAGE for generation of the transformation matrix ([@bb0015]; [@bb0075]). Image registration was verified by a board certified Neuroradiologist via visual inspection using the "Check Results" feature of registration in the Lead-DBS software package (<http://www.lead-dbs.org>).

2.5. Regions of interest {#s0035}
------------------------

Regions of interest were defined for each hemisphere separately in the Montreal Neurological Institute\'s template space and created using the FSLView "atlas" function. The cortical regions of interest for the primary motor cortex, primary sensory cortex, and SMA/PMC were generated from the Montreal Neurological Institute\'s Human Motor Area Template (HMAT) ([@bb0125]). Masks for the prefrontal cortex, occipital lobe, temporal lobe, and parietal lobe were generated by using the Harvard-Oxford cortical atlas. To account for variation between atlases, the HMAT regions of interest were subtracted from those generated by the Harvard-Oxford cortical atlas to ensure no overlap between ROIs. The thalamic regions of interest were generated by using the Harvard-Oxford subcortical atlas. All ROIs were manually verified for accuracy.

2.6. Diffusion data processing {#s0040}
------------------------------

The preprocessed diffusion data were used to estimate voxel-wise diffusion parameters by using Markov chain Monte Carlo sampling in FSL\'s "BEDPOSTX" function. FSL\'s "PROBTRACKX" function was used to perform probabilistic tractography and to calculate the probability of connecting each voxel in the left and right thalamic masks to each of the 7 previously defined cortical target masks. Tracking parameters included the following: total number of samples = 5000; curvature threshold = 0.2; step length = 0.5 mm; and maximum steps = 2000. All voxels within each thalamic mask were then classified by the 1 cortical target region with the greatest number of propagated paths by using FSL\'s "find_the_biggest" function. Each of the normalized 7 thalamic segments were averaged for all 40 patients to generate a group-level probability map for each segment. The probability map was thresholded to \>10% and binarized to generate a connectivity-based group atlas (Supplemental Fig. 2).

2.7. VTA modeling {#s0045}
-----------------

The normalized postoperative computed tomography scan and Lead-DBS software package were used to accurately localize the final DBS electrode position ([@bb0095]). Next, VTA was estimated by using the finite element method and the patient\'s most effective programming settings, as implemented by Horn et al. ([@bb0100]) After VTA was estimated, the volume of overlap between the VTA and each of the 7 thalamic segments was calculated. Additionally, the volume of VTA overlap with the group-averaged SMA/PMC segment and primary motor segment was calculated to compare single-subject results with connectivity-based atlas results.

2.8. Statistical analysis {#s0050}
-------------------------

Continuous variables are summarized as median (range) values. Categorical variables are summarized as the number (percentage) of patients. Associations between the VTA of each thalamic segment (and also total VTA) and the change in the TRS score from the preoperative to 6-month follow-up visit (both raw change and percentage change) were evaluated using linear regression models. In addition to examining the unadjusted models, we also examined multivariable models that were adjusted for age at DBS, sex, disease duration, and side of DBS. Regression coefficients and 95% CI values were estimated and were interpreted as the change in the mean TRS score outcome that corresponded to a specified increase in VTA in the given thalamic segment. When fewer than 5 patients had a VTA \>0 mm^3^ for a given thalamic segment, associations with the change in TRS score outcomes was not assessed because of the lack of variability in the measurements. After excluding these thalamic segments, the association between change in TRS score (both raw change and percentage change) and VTA in 3 thalamic segments (prefrontal cortex, primary motor cortex, and SMA/PMC) and total VTA were evaluated. Spearman\'s correlation coefficient *r* was also estimated in order to further summarize the strength of correlation between VTA parameters and changes in TRS outcomes. After performing a Bonferroni correction for these 4 statistical tests, *P* ≤ .0125 was considered statistically significant, and all tests were 2-sided. Statistical analyses were performed using SAS (version 9.4; SAS Institute Inc) and R Statistical Software (version 3.2.3; R Foundation for Statistical Computing).

3. Results {#s0055}
==========

The patient and DBS characteristics and the outcomes of the 40 patients are summarized in [Table 1](#t0005){ref-type="table"}. The median (range) age at DBS was 70 (39--84) years, and 24 patients (60%) were men. The median (range) disease duration was 19 (5--70) years. Most patients (95.0%) underwent DBS on the opposite side of their dominant hand used for writing and eating. The median (range) preoperative TRS score was 46 (21--74), and the median (range) TRS score at the 6-month follow-up was 24 (4--48). This difference corresponded to a median (range) raw improvement in TRS of 21 points (7-point decrease to 50-point increase), and a median (range) percentage improvement in TRS of 41% (30% worsening to 90% improvement)Table 1Patient and DBS Characteristics and Outcomes.Table 1CharacteristicsValue (*N* = 40)Patient characteristics Age at DBS, median (range), y70 (39 to 84) Men, No. (%)24 (60) Disease duration, median (range), y19 (5 to 70) Right handed, No. (%)35 (87.5)DBS characteristics Side of DBS, No. (%) Left33 (82.5) Right7 (17.5) Handedness/side of DBS Left/right or right/left38 (95.0) Left/left or right/right2 (5)Volume of tissue activated Occipital lobe \>0 mm^3^, No. (%)0 (0.0) Median (range), mm^3^0 (0 to 0) Posterior parietal lobe \>0 mm^3^, No. (%)0 (0.0) Median (range), mm^3^0 (0 to 0) Prefrontal cortex \>0 mm^3^, No. (%)27 (67.5) Median (range), mm^3^20 (0 to 964) Primary motor cortex \>0 mm^3^, No. (%)22 (55.0) Median (range), mm^3^10 (0 to 552) Primary sensory cortex \>0 mm^3^, No. (%)2 (5.0) Median (range) mm^3^0 (0 to 3) Supplementary motor area/premotor cortex \>0 mm^3^, No. (%)40 (100.0) Median (range), mm^3^343 (2 to 1065) Temporal lobe \>0 mm^3^, No. (%)0 (0.0) Median (range), mm^3^0 (0 to 0) Total volume of tissue activated Median (range), mm^3^1007 (294 to 2315)Outcomes, median (range) Preoperative TRS46 (21 to 74) 6-month follow-up TRS24 (4 to 48) Raw change in TRS21 (−7 to 50) Percentage change in TRS41 (−30 to 90)[^1]

The thalamic segmentation results are summarized in [Fig. 1](#f0005){ref-type="fig"} and mirror the segmentation patterns reported in prior studies ([@bb0135]; [@bb0020]). Of the 7 thalamic segments assessed, only 3 segments (prefrontal cortex, primary motor cortex, and SMA/PMC) had at least some VTA overlap in \>5 patients ([Table 1](#t0005){ref-type="table"}); these segments and total VTA were examined for associations with the raw change in the TRS score ([Table 2](#t0010){ref-type="table"}) and percentage change in TRS score (Supplemental Table 1). A significant association between higher VTA in the SMA/PMC segment and greater raw change in TRS score (i.e., greater improvement in symptoms) was noted in the unadjusted analysis (*P* = .001) and in the analysis adjusted for age at DBS, sex, disease duration, and side of DBS (*P* = .001) ([Fig. 2](#f0010){ref-type="fig"}). Specifically, in the adjusted analysis, for every 50 mm^3^ increase in VTA in the SMA/PMC segment, the mean improvement in the TRS score was 1.76 points ([Table 2](#t0010){ref-type="table"}). This finding was consistent in analysis evaluating percentage change in TRS score; a higher VTA in the SMA/PMC segment was associated with a significantly greater percentage change in TRS score in both unadjusted analysis (*P* = .004) and adjusted analysis (*P* = .011) (Supplemental Table 1, Supplemental Fig. 1).Fig. 1Mean Group Thalamic Segmentation Results of 40 Patients. A, Left sagittal view showing the thalamic region most connected to the primary motor cortex (red), primary sensory cortex (green), supplementary motor area and premotor cortex (blue), occipital lobe (yellow), parietal lobe (orange), prefrontal cortex (purple), and temporal lobe (light blue). B, Right sagittal view showing the same regions. C, Superior view. D, Inferior view.Fig. 1Table 2Associations Between VTA and Raw Change in TRS Score for the 40 Patients with Essential Tremor.Table 2Unadjusted Analysis[a](#tf0005){ref-type="table-fn"}Adjusted Analysis[a](#tf0005){ref-type="table-fn"}, [b](#tf0010){ref-type="table-fn"}Brain Segment (Increase in VTA)Regression Coefficient (95% CI)*P* ValueRegression Coefficient (95% CI)*P* ValuePrefrontal cortex (50 mm^3^)−0.89 (−1.84 to 0.06)0.064−0.57 (−1.72 to 0.58)0.32Primary motor cortex (50 mm^3^)1.93 (−0.18 to 4.04)0.0721.48 (−0.76 to 3.71)0.19Supplementary motor area/premotor cortex (50 mm^3^)1.58 (0.75 to 2.41)0.0011.76 (0.76 to 2.76)0.001Total VTA (100 mm^3^)0.12 (−1.19 to 1.42)0.860.09 (−1.20 to 1.38)0.89[^2][^3][^4]Fig. 2Associations Between Raw Change in TRS Score and Volume of Tissue Activated in Different Brain Segments. A, Association between raw change in the TRS score from the preoperative visit to the 6-month follow-up (preoperative score minus 6-month follow-up score) and the volume of tissue activated in the SMA/PMC segment. B, Association between raw change in the TRS score and the volume of tissue activated in the primary motor cortex. C, Association between raw change in the TRS score and the volume of tissue activated in the prefrontal cortex. D, Association between raw change in the TRS score and the total volume of tissue activated. The regression line is shown with a solid line in all graphs. Spearman\'s correlation coefficient *r* is displayed in each graph along with the *p*-value from the multivariable linear regression analysis. PMC indicates premotor cortex; SMA, supplementary motor area; TRS, Tremor Rating Scale.Fig. 2

No significant associations between raw change in TRS score and VTA in the prefrontal cortex or primary motor cortex segments or total VTA were noted in either unadjusted or adjusted analysis (all *P* ≥ .064) ([Table 2](#t0010){ref-type="table"} and [Fig. 2](#f0010){ref-type="fig"}). Similarly, when examining percentage change in TRS, no significant associations with VTA in the prefrontal cortex or primary motor cortex segments or total VTA were observed (all *P* ≥ .13) (Supplemental Table 1, Supplemental Fig. 1). Exemplary subjects are shown in [Fig. 3](#f0015){ref-type="fig"} and Supplemental Fig. 3. Neither the SMA/PMC segment (*P* = .44 for absolute change; *P* = .74 for percentage change) nor the primary motor segment (*P* = .8 for absolute change; *P* = .4 for percentage change) showed a significant correlation with TRS reduction in the group-averaged connectivity-based atlas.Fig. 3Structural-connectivity based segmentation of two exemplary patients. The first patient (left) had a decrease in tremor rating score (TRS) from 63 to 16 (75% decrease) and shows greater overlap of the volume of tissue activated (red) with the region most connected with the supplementary motor area/premotor cortex (yellow). The second patient (right) shows greater overlap of the volume of tissue activated with the region most connected to the primary motor cortex (blue) and only had a decrease in TRS from 34 to 25 (26% decrease).Fig. 3

4. Discussion {#s0060}
=============

Our results suggest that SCBS of the thalamus is an independent predictor of tremor improvement after thalamic DBS. Specifically, we found a significant correlation between greater VTA in the segment most connected to the SMA/PMC (presumably the VO nucleus) and improvement in TRS score as measured by both raw change and percentage change. No significant correlation was found between VTA in the segment most connected to the primary motor cortex (presumably the VIM) and change in TRS score. These findings indicate that this method of preoperative thalamic segmentation may be a valuable supplement to current targeting methods for thalamic DBS and could be used to maximize tremor control. Lastly, utilizing a connectivity-based atlas generated from the same patient group failed to predict change in TRS score as well as the single-subject measures, highlighting the inferiority of of atlas-based measures.

Successful DBS requires accurate preoperative targeting. Widely used indirect thalamic targeting methods rely on atlas- or coordinate-based methods that do not fully account for variations in functional anatomy between patients. Structural connectivity profiles that use fixed coordinate-based targets in the thalamus are widely variable ([@bb0135]). This issue may, in part, contribute to the variability reported in treatment outcomes ([@bb0205]). Although the final electrode position is typically modified using microelectrode recordings, intraoperative macrostimulation, or both, these techniques introduce risk and burden. With each microelectrode recording pass or lead repositioning, the risk of hemorrhage or stroke may increase and the microlesion effect may further limit mapping and complicate intraoperative decision-making ([@bb0190]; [@bb0120]). Improvements in preoperative targeting would likely improve outcomes and reduce complications and stimulation-induced adverse effects. Additionally, noninvasive techniques, such as SRS and MRgFUS, may benefit from improved preoperative targeting because invasive electrophysiologic data cannot be used with these techniques. Finally, lead technologies, such as directional leads, and asleep DBS would also benefit from more accurate delineations of the ideal VTA ([@bb0040]).

The use of structural connectivity as a marker for DBS targeting and outcomes has been previously explored. Horn et al. ([@bb0100]) recently reported that structural connectivity in the subthalamic nucleus is an independent predictor of outcomes in patients with Parkinson disease who receive DBS. Middlebrooks et al. ([@bb0140]) have also shown the potential of structural connectivity within the globus pallidus internus as an independent biomarker for DBS outcomes in Parkinson disease. Previous small clinical studies assessed the structural connectivity profiles in the thalamus used to guide DBS, MRgFUS, and SRS procedures ([@bb0105]; [@bb0160]; [@bb0195]). The correlation between SCBS and brain segments in patients who received DBS was first reported by Pouratian et al. ([@bb0160]); they found that the optimal DBS contact was closer to the segment most connected to the PMC than the primary motor cortex in a series of 6 patients with ET. Importantly, this novel pilot study had some notable limitations. The optimal DBS contact used was localized, but no VTA was determined from the stimulation parameters that were used to quantitatively assess the overlap between the thalamic segment and activated tissue. In addition, patients with bilateral leads were assessed, which may have limited the ability to discern the therapeutic effect of each DBS lead ([@bb0170]). Nevertheless, the insights provided by this pilot study have been applied to noninvasive techniques, including a case report of SRS thalamotomy and a report of series of 12 patients who underwent MRgFUS thalamotomy. These studies collectively support the finding of improved outcomes when using the thalamic region most connected to the PMC ([@bb0105]; [@bb0160]).

Importantly, other potential connectivity targets have been proposed for ET DBS, most notably the dentato-rubro-thalamic tract ([@bb0050]; [@bb0045]; [@bb0055]; [@bb0060]). Akram et al. ([@bb0010]) recently reported a comparison of probabilistic tractography--based thalamic segmentation with probabilistic fiber tracking of the dentato-rubro-thalamic tract in a series of patients with Parkinson disease and ET who underwent DBS. Their study reported that patients with a greater improvement in tremor score had more VTA overlap with the dentato-rubro-thalamic tract (thereby closely mirroring the probabilistic tractography--based primary motor cortex segment) rather than the thalamic SMA/PMC segment ([@bb0010]). The authors attributed this discrepancy in their findings compared with the findings of Pouratian et al. ([@bb0160]) to the poor angular resolution, spatial resolution, and angular contrast used in Pouratian et al.\'s study ([@bb0010]). Despite these findings, we found similar results as reported by Pouratian et al. ([@bb0160]) in our protocol that utilized higher angular resolution and higher spatial resolution than the original studies of Pouratian et al. ([@bb0160]) The contradiction between our current study and Akram et al.\'s study ([@bb0010]) could be related to the small number of patients enrolled in their study (40 vs 9 patients, respectively), thereby preventing statistical correlation, or due to the lack of significant stimulation within the SMA/PMC segment. Alternatively, the use of group mean values to describe thalamic segmentation in Akram et al.\'s study ([@bb0010]) limits determination of the effects of DBS in each patient relative to VTA overlap in each segment, particularly given the known inter- and intrapatient variations ([@bb0135]). Additionally, Nowacki et al. were unable to reproduce the correlation between dentato-rubro-thalamic proximity and tremor reduction ([@bb0145]). Because the thresholds for angular resolution, spatial resolution, and angular contrast needed to accurately assess the response to DBS have yet to be determined, attributing differences in outcomes to such imaging parameters is speculative, at this time. Future studies will be needed to further elucidate the basis of discrepancies in these collective studies.

In our current study of 40 patients who underwent VIM DBS for tremor, we showed the value of using SCBS to predict the degree of improvement in TRS score. By modeling VTA in each patient and by analyzing the volume of VTA overlap with each thalamic segment, we demonstrated that the VTA within the segment most connected to the SMA/PMC was correlated with tremor reduction as measured by the change in the TRS score. Our study design included only patients with unilateral lead placement in order to avoid potential confounders related to the effects of DBS on ipsilateral tremor and to avoid violating the statistical assumption of independent measurements in patients with bilateral leads.

The mechanistic underpinnings of tremor control by VIM DBS remain debatable. While VIM has traditionally been considered the intended target, other DBS targets have been suggested such as the subthalamic nucleus ([@bb0030]), prelemniscal radiations ([@bb0200]), VO thalamic nucleus ([@bb0085]), caudal zona incerta ([@bb0155]), and dentato-rubro-thalamic tract ([@bb0050]; [@bb0060]). Because no specific target or targeting mechanism has been shown to be entirely predictive of outcomes, the underlying pathophysiology and treatment effects are likely multifactorial. However, our finding that the ideal VTA overlaps with the SMA/PMC segment (presumably the VO nucleus) was corroborated by electrophysiologic and clinical studies that showed effective tremor reduction with VO stimulation ([@bb0080]; [@bb0085]; [@bb0165]; [@bb0210]). The effect of VO stimulation has also been clinically shown with improvement in tremor control in patients whose VIM DBS initially failed. In these cases, a VO rescue lead was placed anterior to the previously placed VIM lead ([@bb0150]; [@bb0175]). Other groups have proposed that stimulation of the pallidal-receiving neurons in the VO region of the thalamus may be another therapeutic target for tremor control ([@bb0130]; [@bb0215]; [@bb0085]).

Several limitations of our study are noteworthy. First, because of the relatively small sample size, there was limited power to detect associations between VTA and changes in the TRS scores. Although we were able to demonstrate a significant association between VTA in the SMA/PMC region and change in TRS score despite this lack of power, the possibility of a type II error (ie, a false-negative finding) is important when considering the other findings. Second, a greater number of patients had a preferential stimulation in the SMA/PMC segment relative to the M1 segment. While this is potentially a bias introduced by the use of intra-operative recordings resulting in repositioning of the target in attempt to achieve maximum therapeutic response, this is speculative given the retrospective nature of the study. Similar positional stimulation bias in other studies limits comparability of treatment response with each target and future studies are needed to fully elucidate the difference in effect of both targets ([@bb0010]). Third, spatial precision in functional neurosurgery is critically important; however, the ideal spatial resolution for accurate targeting with diffusion tensor imaging is currently unknown. Likewise, the accuracy of segmentation is potentially limited by the angular resolution of diffusion tensor imaging, and the number of ideal diffusion directions remains unknown. Our study, in contradistinction from several prior studies, used higher angular and spatial resolution yet found similar results ([@bb0105]; [@bb0160]; [@bb0195]; [@bb0060]). Interestingly, the only similar study using even higher spatial and angular resolution reported contradictory results, which may have been related to the small sample size and use of group mean thalamic segmentation values ([@bb0010]). Unfortunately, because multiple protocols were not tested to compare these methods, it remains unknown if these factors will alter potential target points and stimulation volumes. Lastly, the geometric distortion inherent to echo-planar imaging may affect spatial localization after rigid image registration, and these changes could not be completely corrected in this retrospective data set. Our future acquisition methods will implement more accurate methods to estimate the susceptibility-induced off-resonance field for distortion correction and could be used to ascertain the potential effects on spatial localization of thalamic segments. Despite these limitations, the predictability of the proposed model and associated tremor outcomes is intriguing and warrants continued investigation.

5. Conclusions {#s0065}
==============

The results of this study suggest that a larger VTA in the SMA/PMC thalamic segment during DBS is associated with a significant improvement in TRS scores in patients with ET. No associations between change in TRS score and VTA in the prefrontal cortex or primary motor cortex segments or total VTA were noted. Although prospective studies are needed to validate the added benefit of SCBS compared with traditional indirect targeting methods alone, our findings support the potential role of thalamic SCBS as an independent preoperative predictor of tremor improvement in patients who undergo VIM DBS.
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[^1]: Abbreviations: DBS, deep brain stimulation; TRS, Tremor Rating Scale.

[^2]: Abbreviations: DBS, deep brain stimulation; TRS, Tremor Rating Scale; VTA, volume of tissue activated.

[^3]: Regression coefficients, 95% CIs, and *P* values were determined using linear regression models. The regression coefficient indicates the change in the mean raw change in TRS score (preoperative score minus the 6-month follow-up score) that corresponds to the increase in VTA shown in parentheses for each brain segment.

[^4]: Adjusted for age at deep brain stimulation, sex, disease duration, and side of DBS.
